Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioWorks is a biotechnology company that develops and markets environmentally responsible biological control products for the horticulture and agriculture industries. Based in Victor, New York, the company provides biopesticides, biofungicides, and biostimulants designed to reduce reliance on synthetic chemicals. Their portfolio includes well-known brands like RootShield, BotaniGard, and CEASE, which utilize beneficial microorganisms to protect crops from pathogens and pests. In 2023, BioWorks was acquired by Biobest Group, a global leader in biological control and pollination, to strengthen its presence in the North American market. The company continues to operate as a key subsidiary, focusing on sustainable crop protection and integrated pest management solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioWorks.